Objective: To report the latest conditional survival estimates for patients with cancer in Queensland, Australia.
Design, setting and participants: Descriptive study of state-wide population-based data from the Queensland Cancer Registry on patients aged 15–89 years who were diagnosed with invasive cancer between 1982 and 2007.
Main outcome measure: Conditional 5-year relative survival for the 13 most common types of invasive cancer, and all cancers combined.
Results: The prognosis for patients with cancer generally improves with each additional year that they survive. A significant excess in mortality compared with the general population ceases to occur within 10 years after diagnosis for survivors of stomach, colorectal, cervical and thyroid cancer and melanoma, with these groups having a conditional 5-year relative survival of at least 95% after 10 years. For the remaining cancers we studied (pancreatic, lung, breast, prostate, kidney, and bladder cancer, non-Hodgkin lymphoma, and leukaemia), conditional 5-year relative survival estimates (at 10 years after diagnosis) ranged from 82% to 94%, suggesting that patients in these cohorts continue to have poorer survival compared with the age-matched general population.
Conclusions: Estimates of conditional survival have the potential to provide useful information for cancer clinicians, patients and their carers as they are confronted by personal and surveillance-related decisions. This knowledge may be effective in building realistic hope and helping people manage uncertainty about the future. We suggest that measures of conditional survival be incorporated into routine statistical reporting in Australia.
- 1. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality (ACIM) Books [Internet]. Canberra: AIHW, 2010. http://www.aihw.gov.au/cancer/data/acim_books/index.cfm (accessed Nov 2010).
- 2. Australian Institute of Health and Welfare, Cancer Australia and Australasian Association of Cancer Registries. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer Series no. 42. Canberra: AIHW, 2008. (Cat. no. CAN 38.) http://www.aihw.gov.au/publications/index.cfm/title/10484 (accessed Nov 2010).
- 3. Xing Y, Chang GJ, Hu CY, et al. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010; 116: 2234-2241.
- 4. Yang YH, Liu SH, Ho PS, et al. Conditional survival rates of buccal and tongue cancer patients: how far does the benefit go? Oral Oncol 2009; 45: 177-183.
- 5. Chang GJ, Hu CY, Eng C, et al. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 2009; 27: 5938-5943.
- 6. Alanee S, Shukla A. Paediatric testicular cancer: an updated review of incidence and conditional survival from the Surveillance, Epidemiology and End Results database. BJU Int 2009; 104: 1280-1283.
- 7. Choi M, Fuller CD, Thomas CR Jr, et al. Conditional survival in ovarian cancer: results from the SEER dataset 1988–2001. Gynecol Oncol 2008; 109: 203-209.
- 8. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognosis for long-term survivors of cancer. Ann Oncol 2007; 18: 1408-1413.
- 9. Janssen-Heijnen ML, Gondos A, Bray F, et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 2010; 28: 2520-2528.
- 10. Bowles TL, Xing Y, Hu CY, et al. Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol 2010; 17: 2015-2023.
- 11. Hahnel R, Spilsbury K. Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients. ANZ J Surg 2004; 74: 957-960.
- 12. Woods LM, Rachet B, O’Connell D, et al. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009; 124: 2391-2399.
- 13. Queensland Cancer Registry, Cancer Council Queensland and Queensland Health. Cancer in Queensland: incidence, mortality, survival and prevalence, 1982 to 2007. Brisbane: Cancer Council Queensland, 2010.
- 14. Brenner H, Gefeller O, Hakulinen T. Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40: 326-335.
- 15. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological Note No. 10. Bethesda, MD: National Cancer Institute, 1959.
- 16. Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003; 21: 3035-3040.
- 17. McDowell ME, Occhipinti S, Ferguson M, et al. Predictors of change in unmet supportive care needs in cancer. Psychooncology 2010; 19: 508-516.
- 18. Hart SL, Latini DM, Cowan JE, et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer 2008; 16: 161-169.
- 19. Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34 963 patients with invasive carcinoma of the colon. Dis Colon Rectum 1998; 41: 1097-1106.
- 20. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 1995; 4: 523-531.
- 21. National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer. Sydney: NBBC, 2003. http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/cp90.pdf (accessed Nov 2010).
- 22. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 2008; 58: 180-190.
- 23. Mller KD, Triano LR. Medical issues in cancer survivors — a review. Cancer J 2008; 14: 375-387.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.